Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV003411123 | SCV004137358 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | AHNAK2: BP4, BS2 |
Ambry Genetics | RCV004621789 | SCV005115705 | uncertain significance | not specified | 2024-04-19 | criteria provided, single submitter | clinical testing | The c.4970A>G (p.K1657R) alteration is located in exon 7 (coding exon 7) of the AHNAK2 gene. This alteration results from a A to G substitution at nucleotide position 4970, causing the lysine (K) at amino acid position 1657 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |